Helmstaedter, Christoph http://orcid.org/0000-0002-6608-6244
Hansen, Niels
Leelaarporn, Pitshaporn
Schwing, Kerstin
Oender, Demet
Widman, Guido
Racz, Attila
Surges, Rainer
Becker, Albert
Witt, Juri-Alexander
Article History
Received: 29 May 2020
Revised: 30 July 2020
Accepted: 10 August 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: Dr. Becker has no disclosures. Dr. Hansen has no disclosures. Dr. Helmstaedter reports grants from EU Grant E-Epilepsy, personal fees and non-financial support from UCB, personal fees from EISAI, non-financial support from Desitin Pharma, personal fees from GW-Pharma, grants from EpiCare European Network (ERN), personal fees from Precisis AG, outside of the submitted work; In addition, Dr. Helmstaedter has a patent Trade Mark EpiTrack® with royalties paid. Ms. Leelaarporn has no disclosures. Ms. Oender has no disclosures. Dr. Racz has no disclosures. Ms. Schwing has no disclosures. Dr. Surges reports personal fees from Bial, personal fees from Eisai, personal fees from LivaNova, personal fees from Novartis, personal fees from Desitin, personal fees from UCB Pharma, outside of the submitted work; Dr. Widman has no disclosures. Dr. Witt reports personal fees from Eisai, outside of the submitted work.
: The study was approved by our local Ethics Committee (# 222/16).
: Written informed consent was obtained from all patients.